Cochrane: honey rated better for children’s cough than some OTC preps or placebo

Cochrane: honey rated better for children’s cough than some OTC preps or placebo

April 16 2018 Honey appears likely to help children’s cough more than diphenhydramine, a...

OTC Viagra Connect availability to widen following launch via Boots

OTC Viagra Connect availability to widen following launch via Boots

April 11 2018 Viagra Connect should be available from most pharmacies at the end of this week,...

MHRA issues warning over flammability of headlice treatments

MHRA issues warning over flammability of headlice treatments

March 9 2018 Pharmacists have been asked to tell customers about the risk of fire when discussing...

OTC industry proposes maximum level for vitamin D in food supplements

OTC industry proposes maximum level for vitamin D in food supplements

March 6 2018 Food supplement manufacturers are proposing to set the maximum dose of vitamin D at...

Specific nutrients or food supplements do not reduce dementia risk, based on current evidence

Specific nutrients or food supplements do not reduce dementia risk, based on current evidence

March 5 2018 There is no evidence to show any specific nutrient or food supplement affects the...

  • Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Monday, 16 April 2018 09:13
  • OTC Viagra Connect availability to widen following launch via Boots

    OTC Viagra Connect availability to widen following launch via Boots

    Wednesday, 11 April 2018 12:52
  • MHRA issues warning over flammability of headlice treatments

    MHRA issues warning over flammability of headlice treatments

    Friday, 09 March 2018 16:15
  • OTC industry proposes maximum level for vitamin D in food supplements

    OTC industry proposes maximum level for vitamin D in food supplements

    Tuesday, 06 March 2018 12:24
  • Specific nutrients or food supplements do not reduce dementia risk, based on current evidence

    Specific nutrients or food supplements do not reduce dementia risk, based on current evidence

    Monday, 05 March 2018 12:11

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a male vector imageApril 11 2018

Viagra Connect should be available from most pharmacies at the end of this week, following a two-week exclusive launch period through Boots the Chemist.

Pfizer launched the over-the-counter version of sildenafil on March 27, having been granted a Pharmacy (P) medicine licence last autumn. In the meantime, it has been supplying training material to pharmacies, for pharmacists to sell the product to adult males with erectile dysfunction.

Pharmacists will also be expected to advise customers to follow-up with their GP at their earliest convenience. The OTC product is contraindicated for a range of conditions and should not be sold to men who do not have ED.

Viagra Connect has been launched with a recommended retail price of £19.99 for a 4-tablet pack or £34.99 for an 8-tablet pack, including VAT.

Pharmacist Kristie Sourial, Medical Manager, Pfizer, said: “The launch of Viagra Connect offers men a new and convenient route of access to treat the symptoms of erectile dysfunction. It’s important to remember that erectile dysfunction is a medical condition, and that the impact often goes beyond the physical symptoms – it can lead to men feeling anxious, depressed and lacking in confidence.

“Our hope is that the availability of Viagra Connect in pharmacies will encourage men who do nothing about their ED to seek help, and encourage those who are inclined to seek help to do so sooner.”

Boots added that men seeking to purchase the product from Boots online have to complete a short questionnaire at www.boots.com/viagraconnect, with their answers being reviewed by a pharmacist to determine if the product is right for them.

The Royal Pharmaceutical Society said it “fully supports the move to make sildenafil available at community pharmacies as a P medicine so it can be provided directly by pharmacists after a consultation with a patient about erectile dysfunction.”

RPS President Ash Soni added: “Discussing health problems with patients and advising on the benefits and risks of treatments is integral to the role of the pharmacist. Men can be assured that well over 90% of pharmacies have private consultation areas, meaning conversations cannot be overheard.

“One of the underlying causes of erectile dysfunction is cardiovascular disease, so this move will bring more men into the healthcare system where they can get proper advice and onward referral if necessary.”

Pfizer estimates that erectile problems affect up to 21% of UK men. However, “a new study shows that 44% of men with erectile dysfunction aged 40 and over have not sought medical help, even though it can have a significant impact on their confidence and self-esteem. Of those men that have sought help, over one fifth (27%) admitted that they wished that they had sought help sooner.”

Links:
Boots announcement  
Pfizer announcement  
RPS comment  
Today’s Pharmacist coverage of Viagra Connect approval          

OTC News

April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...
April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...